Governor Kathy Hochul has removed Felicia Reid from her post as acting executive director of the New York State Office of Cannabis Management. The move is seen as a sudden shakeup prompted by the agency’s handling of enforcement efforts against unlicensed marijuana operators. Reid, who has led the office since June 2024, was asked to …
Category: News
Study: Tailored Full-Spectrum Marijuana Extracts Linked to Broad Benefits for Women With Chronic Pain
A new study in Frontiers in Pharmacology finds that full-spectrum marijuana extracts, used with flexible, individualized dosing, were associated with broad improvements for women living with chronic pain syndromes. The research team from Centro Universitário Unieuro, the State Secretariat of Education of the Federal District and the University of Brasilia analyzed outcomes for 29 Brazilian …
New Study Unveils High-Precision Technique for Testing Cannabinoids in Oils and Flower
A team of researchers from Brazil has developed a highly sensitive lab method that could help regulators and producers more accurately measure key cannabinoids in marijuana oils and dried flower. They team from the Federal University of Espírito Santo reports their findings in a study published by ACS Omega.
Maine Marijuana Sales Reach $230 Million in 2025 as Prices Reach New All-Time Low in November
Maine’s adult-use marijuana market posted steady gains in November even as prices continued their sharp downward slide, with the state hitting a new all-time low for the average price of bud and flower. According to new data from the Office of Cannabis Policy, retailers reported $19.19 million in November sales, generated across more than 381,000 …
Study: Cannabis-Based Medicines Linked to Long-Term Quality-of-Life Improvements in Multiple Sclerosis Patients
A study from researchers at Imperial College London and Kings College London reports that people living with multiple sclerosis (MS) experienced sustained improvements in quality of life after beginning treatment with cannabis-based medicinal products, with benefits observed for up to two years. Published in the journal Medical Cannabis and Cannabinoids and published online by the …
Michigan Judge Rules New 24% Marijuana Wholesale Tax Can Take Effect January 1
Judge Sima Patel of the Michigan Court of Claims issued a decision today denying industry groups’ request to pause Michigan’s new 24% wholesale marijuana tax, clearing the way for it to take effect January 1. The ruling delivers an early win for Governor Gretchen Whitmer, who initially proposed the tax increase.
Study: Rare Varin Cannabinoids Show Potent Anticancer Activity in Lab Tests
A new study published in Natural Product Research reports that two rare varin-type cannabinoids may offer meaningful anticancer potential, with researchers identifying strong cytotoxic effects in breast and colon cancer cell lines. The work was conducted by a team at the Indian Institute of Integrative Medicine, who developed a method to generate hard-to-access cannabinoids from …
Global Cannabis Testing Services Market Set to More Than Double by 2030, From $1.5 Billion to $3.8 Billion
New projections show the global cannabis testing services market on track to more than double within the decade, growing from $1.51 billion in 2024 to $3.79 billion by 2030. The upward trajectory, driven by a 16.58% CAGR (compound annual growth rate) reflects the continued legalization of marijuana worldwide and a tightening regulatory environment that requires …
One in Three Older Caregivers Use Marijuana, Study Finds
A new study published in Cannabis and Cannabinoid Research offers one of the most detailed looks to date at marijuana use among Californians over 50 who serve as informal caregivers. The analysis, conducted by scientists from the University of Iowa, the University of California San Diego, and the University of Arkansas, used responses from nearly …
THC-Based Medication Reduced Agitation in Alzheimer’s Patients in Randomized Clinical Trial
A randomized clinical trial published in The American Journal of Geriatric Psychiatry found that dronabinol, a medication made with synthetic THC, reduced agitation in patients with Alzheimer’s disease over a three-week treatment period. The research team, based at Johns Hopkins University School of Medicine and several collaborating centers, conducted the trial across five inpatient and …
Sponsored
